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Objectives The purpose of this study was to evaluate the incidence and prognostic implication of diastolic dysfunction (DD)
occurring in the first year after transplant.
Background Diastolic dysfunction is a recognized complication in heart transplant recipients, but its true incidence and natu-
ral history has been poorly characterized. We studied the prognostic implication of DD, as defined by elevated
filling pressures with normal systolic function, occurring in the first year after transplant.
Methods Between June 1992 and June 2002, all patients who underwent heart transplantation at a single institution
were included in the study (231 at 6 weeks and 250 at 6 months and 1 year). Diastolic dysfunction was defined
as right atrial pressure (RAP) 15 mm Hg (right ventricular [RV] DD) or pulmonary capillary wedge pressure
18 mm Hg (left ventricular [LV] DD) with normal systolic function by echocardiogram and without severe mitral
or tricuspid insufficiency. In addition, RV DD was defined by a RAP/stroke volume (SV) ratio.
Results The incidence of DD was 22%, 8%, and 12% at 6 weeks, 6 months, and 1 year, respectively. The incidence of LV
DD was more frequent than that of RV DD at any time point (p  0.0001). By multivariable analysis RV DD, as
manifested by an elevated RAP/SV, but not LV DD was a strong predictor of cardiac mortality at all time points.
Conclusions Diastolic dysfunction is common early after transplant, and its incidence decreases during the first year. Right
ventricular DD, as measured by an elevated RAP/SV ratio, but not LV DD is a strong predictor of cardiac mortal-
ity. Further studies are needed to evaluate the functional status of patients with RV or LV DD and whether ag-
gressive medical therapy for early DD could alter outcome. (J Am Coll Cardiol 2007;50:1064–9) © 2007 by
the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.06.007i
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fiastolic dysfunction (DD) is a well-recognized complica-
ion after heart transplantation. During the first few days to
eeks after heart transplantation, the right atrial pressure
RAP) and left atrial pressure are often elevated, reflecting
ecreased compliance of the transplanted heart (1). How-
ver, these abnormalities tend to resolve in subsequent
eeks in the majority of patients. Acute rejection might play
n important role in the development of abnormal diastolic
unction, at least acutely (2). In contrast, the causes and
mplications of chronic DD of the heart allograft are less
lear. Anecdotal evidence and small studies suggest that
ost-transplant DD is poorly tolerated and might be asso-
iated with graft loss and decreased survival (3). Therefore,
he objective of this study was to evaluate the time-related
rom the Departments of *Cardiovascular Disease and †Cardiovascular Surgery,
niversity of Alabama at Birmingham, and the ‡Department of Medicine, Birming-
am VA Medical Center, Birmingham, Alabama. §In memoriam. Sharon Hunt,
D, FACC, served as Guest Editor for this article.m
Manuscript received August 21, 2006; revised manuscript received May 18, 2007,
ccepted June 4, 2007.ncidence of post-transplant DD during the first year after
ransplantation and the impact of right ventricular (RV)
ersus left ventricular (LV) DD on subsequent survival.
ethods
atient population. A retrospective analysis was con-
ucted of all patients who underwent heart transplantation
t the University of Alabama at Birmingham between July
992 and June 2002. A total of 294 patients were trans-
lanted. Of these, 273 patients survived at least 1 year and
omprise the study group. If the hemodynamic or echocar-
iographic data were not available in a particular time point,
hen the patient was not included in the analysis for that
ime point.
efinitions. The diagnosis of DD was determined during
ight heart catheterization, which is a routine part of the
ndomyocardial biopsy protocol at our institution. The
iagnosis of DD required normal RV and LV ejection
raction and the absence of at least moderate-to-severe
itral or tricuspid valve regurgitation as evaluated by
e
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September 11, 2007:1064–9 Post-Transplant Diastolic Dysfunctionchocardiography. Right ventricular DD was defined by 1 of
criteria. A RAP15 mm Hg was the primary criterion for
V DD. In addition, RV DD was also defined by the
elationship of RAP to stroke volume (SV) (thermodilution
ardiac output divided by heart rate). In light of the variable
elationship between these 2 variables, DD was examined as
continuous variable—higher values of RAP/SV indicating
reater degrees of RV DD. Left ventricular DD was
imilarly defined as pulmonary capillary wedge pressure
PCWP)18 mm Hg or as a continuous variable by higher
alues of PCWP/SV. Cardiac death was defined as death
ttributed to coronary allograft vasculopathy, graft failure,
ejection, sudden cardiac death, and death due to unknown
ause.
ata collection. The clinical data were collected from the
ardiac Transplant Research Database forms and included
re-transplant donor and recipient factors, perioperative
actors, and typical post-transplant characteristics. The de-
ographic variables collected on all patients included age,
ace, gender, height, weight, body mass index, pre-
ransplant heart disease, and transplant date. Clinical vari-
bles collected included detailed history of immunosuppres-
ant and nonimmunosuppressant medications, rejection
istory including number of treated rejections, lipid levels,
resence of diabetes mellitus, hypertension, history of to-
acco use and cytomegalovirus serology, and infections.
ata were collected from the right heart catheterization and
chocardiograms closest to the time points of 6 weeks, 6
onths, and 1 year after transplant. This study was ap-
roved by the Institutional Review Board at the University
f Alabama at Birmingham.
nalysis. Descriptive statistics were computed for each
ariable at baseline (% for discrete variables, mean 
tandard deviation for continuous variables) and compared
etween groups with chi-square and t tests, respectively.
utcomes were assessed within groups with paired t testing.
values of 0.05 were considered significant. Predictors of
ardiac death were examined by multivariable analysis in the
azard function domain. Variables entered into the multi-
ariable analysis are those listed under the section “Data
ollection.” Patients were censored at the time of death
rom “noncardiac” causes. Cardiac death was examined after
he first post-transplant year, and the predictive value of DD
as examined at the time points of 6 weeks, 6 months, and
year.
esults
tudy population. Two hundred seventy-three patients
ere included in the study. Of these, 16, 20, and 15 were
xcluded at 6 weeks, 6 months, and 1 year, respectively,
ecause of depressed ejection fraction (n  2, 7, and 4,
espectively) or significant tricuspid regurgitation (n  13,
3, and 10, respectively). In addition, there was 1 patient
ith both (depressed ejection fraction and tricuspid regur- witation) at 6 weeks and 1 year.
one of the patients in the study
ad significant mitral regurgita-
ion. The total number of pa-
ients included in the analysis
as 231 at 6 weeks and 250 at 6
onths and 1 year. The baseline
haracteristics of the population
tudied are summarized in Table
. As expected, the hemody-
amic parameters measured, like
ean pulmonary artery, RA, and
CWP pressures, were significantly higher in the group of
atients with DD, but surprisingly, the transpulmonary
radient was not statistically significant. Other important
ariables, like recipient height and weight and ischemic
ime, were only significantly different at 6 months but not at
weeks and 1 year.
ncidence of DD. The incidence of any post-transplant
D was 22% (n  50), 8% (n  20) and 11% (n  28) at
weeks, 6 months and 1 year, respectively. The incidence of
V DD (PCWP18 mm Hg) was more frequent than that
f RV DD (RAP 15 mm Hg) at any time point (p 
.0001). The incidence of LV DD was 21% (n  48), 8%
n  20) and 10% (n  25) at 6 weeks, 6 months, and 1
ear, respectively, whereas the incidence of RV DD was 3%
n  7), 1% (n  2), and 3% (n  7), respectively, at the
ame time points.
V DD. By univariate analysis, the presence of early LV
D (as defined by PCWP 18 mm Hg) was predictive of
V DD at 1 year. Specifically, the likelihood of LV DD at
year was 20% when LV DD was present at 6 weeks versus
% when not present at 6 weeks (p  0.02). However, LV
D at 1 year, defined by PCWP alone or PCWP/SV, was
ot an independent predictor (by multivariable analysis) of
ubsequent mortality.
V DD. Although RV DD (as defined by RAP 15 mm
g) was much less common than LV DD, the early
resence of RV DD at 6 weeks was predictive of RV DD at
year. The likelihood of RV DD at 1 year was 40% when
resent at the 6 weeks catheterization versus 2% when not
resent (p  0.0001).
ortality. By multivariable hazard function analysis, RV
D was a significant predictor of cardiac death. The ratio of
AP/SV was a stronger predictor than RAP alone
Table 2). Right ventricular DD at all 3 time points after
ransplant was predictive of subsequent mortality, but later
dentification (or possibly persistence) of RV DD had
reater predictive value, both for RAP alone (Fig. 1) and
AP/SV (Fig. 2). Viewed from an actuarial perspective, RV
D that persisted from an earlier catheterization study was
ssociated with particularly poor late survival (Fig. 3). None
f the other characteristics analyzed, including the pre- and
ost-transplant baseline characteristics included in Table 1,
Abbreviations
and Acronyms
DD  diastolic dysfunction
LV  left ventricular
PCWP  pulmonary
capillary wedge pressure
RAP  right atrial pressure
RV  right ventricular
SV  stroke volumeere significant predictors of cardiac mortality.
Baseline Characteristics of the Patients Included in the Study
Table 1 Baseline Characteristics of the Patients Included in the Study
Recipient Characteristics
6 Weeks 6 Months 1 Yr
No DD DD p Value No DD DD p Value No DD DD p Value
Age (yrs) 52 10.7 50 11.3 0.2 51 11.0 52 9.6 0.8 52 10.5 50 8.6 0.3
Gender (% male) 79% 80% 0.95 80% 88% 0.4 80% 88% 0.3
Ethnicity (% black) 11% 14% 0.65 13% 12% 0.9 11% 12% 0.95
Etiology (% ischemic) 56% 50% 0.5 54% 76% 0.07 57% 54% 0.7
History of renal insufficiency 7% 9% 0.7 9% 6% 0.7 9% 4% 0.4
Creatinine clearance at
listing (geometric means)
73 (31.2, 21.9) 77 (25.1, 18.9) 0.4 73 (30.5, 21.5) 77 (25.4, 19.1) 0.5 73 (29.2, 20.9) 73 (42.6, 26.9) 1.0
Serum creatinine at transplant
(geometric means)
1.2 (0.42, 0.31) 1.3 (0.41, 0.31) 0.26 1.2 (0.42, 0.32) 1.2 (0.35, 0.27) 0.5 1.2 (0.43, 0.32) 1.3 (0.25, 0.21) 0.1
Height (cm) 174 8.5 175 9.7 0.8 175 8.8 177 8.2 0.2 175 9.1 177 6.5 0.1
Weight (kg) 79 14.8 83 16.8 0.1 79 15.5 87 9.5 0.004 79 15.1 89 15.3 0.6
Donor characteristics
Age (yrs) 26 9.4 30 11.3 0.02 26 9.8 23 8.3 0.2 26 9.6 25 10.3 0.8
Gender (% male) 79% 77% 0.7 78% 94% 0.14 78% 85% 0.4
Ethnicity (% black) 19% 14% 0.4 19% 12% 0.5 20% 15% 0.6
Height (cm) 177 10.3 177 9.3 0.9 177 10.3 179 3.6 0.02 177 10.3 177 8.2 0.9
Weight (kg) 76 16.4 77 15.2 0.7 76 16.3 75 7.7 0.8 76 16.2 74 10.7 0.5
Ischemic time (min) 187 70.8 193 60.8 0.6 182 67.7 217 73.8 0.04 187 69.5 180 57.3 0.6
Invasive characteristics
(post-transplant)
Mean RAP (mm Hg) 6 2.8 10 3.9 0.0001 5 2.7 12 4.5 0.0001 6 2.7 13 4.4 0.0001
Mean PCWP (mm Hg) 11 3.5 21 3.4 0.0001 10 3.5 21 3.6 0.0001 11 3.3 20 3.3 0.0001
Mean PA pressure (mm Hg) 20 5.7 29 5.3 0.0001 20 8.1 28 4.4 0.0001 20 4.6 28 4.0 0.0001
Mean transpulmonary
gradient
9 3.8 8 4.3 0.09 9 3.3 7 4.4 0.01 9 3.5 8 3.4 0.2
The patients are grouped on the basis of the presence or absence of diastolic dysfunction (DD) at each time point.
PA  pulmonary artery; PCWP  pulmonary capillary wedge pressure; RAP  right atrial pressure.
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ncreased filling pressures during the early post-transplant
eriod are likely related to prolonged ischemic time, donor–
ecipient size mismatch, operative technique (1,4,5), and
llograft rejection (6). The decreasing incidence of DD over
ime in the present study is consistent with prior studies,
uggesting that after the first few weeks, the restrictive
hysiology of the non-rejecting allograft tends to subside,
ith normalization of the diastolic parameters (7,8). How-
ver, the presence of early DD identifies a group of patients
ith an important incidence of DD at 1 year and with a
igher likelihood of poor outcome. The incidence of LV
D is more frequent than that of RV DD, which is not
urprising given the higher volume mass and susceptibility
o ischemia of the left ventricle and its greater dependence
n pre-load and afterload hemodynamic changes. Interest-
ngly, none of the usual parameters associated with DD, like
ge, ischemic time, donor or recipient size, or prior thoracic
urgery was consistently different among the patients with
nd without DD.
Post-transplant DD has significant prognostic implica-
ions. A study done by Ross et al. (9) suggests that the
Risk Factors for Cardiac Mortality
Table 2 Risk Factors for Cardiac Mortality
Variable
6 Weeks
RR p Value
Younger recipient age 1.6* 0.001
Higher % IBW 2.0† 0.02
Earlier date of transplant 2.9‡ 0.03
Female recipient NS
Higher RAP/SV 2.7§ 0.02
Cardiac mortality defined as death after the specified cardiac cathe
comparing % ideal body weight (IBW)  125% to % IBW  100%. ‡
right atrial pressure/stroke volume (RAP/SV)  250 versus RAP/SV 
Figure 1 RAP and Cardiac Mortality
Relationship between mean right atrial pressure (RAP) and the likelihood of
subsequent cardiac mortality. The lines for each time point are essentially
superimposable. The dashed lines represent the 20% confidence limits. cath 
catheterization; Tx  transplant; UAB  University of Alabama at Birmingham.ersistence of abnormal diastolic parameters by Doppler
chocardiography after the first few weeks after transplant is
ssociated with increased late mortality, independent of
ther risk factors that might increase filling pressures, like
ejection and allograft vasculopathy. Similarly, a recent
tudy by Aziz et al. (10) found that the presence of DD,
easured primarily by echocardiographic indexes 2 years
fter transplantation, was associated with symptoms of heart
ailure and possibly a decreased survival 2 to 5 years after
ransplantation. However, these studies were based on
oppler echocardiographic parameters only and not on
levated filling pressures measured by a pulmonary artery
atheter or direct LV measurement. Moreover, the latter
tudy did not exclude patients with rejection, which is
nown to affect the Doppler diastolic parameters (6).
Several factors were associated with mortality in our study
hen included in a multivariable analysis as described in
able 2. The most important finding of our study is that the
resence of RV DD, but not LV DD, is a strong predictor
f cardiac mortality. Interestingly, evaluating the right-sided
lling pressures is part of the physical exam in post-
ransplant patients, and the finding of an elevated jugular
Figure 2 RAP/SV and Cardiac Mortality
Univariable depiction of the relationship between mean RAP divided by stroke
volume (SV) and predicted cardiac mortality at 3 time points. Abbreviations as
in Figure 1.
6 Months 1 Yr
RR p Value RR p Value
1.6 0.003 NS
1.9 0.04 2.0 0.05
4.1 0.01 3.75 0.05
2.9 0.02 3.5 0.008
2.5 0.003 3.6 0.002
n. *Relative risk (RR) comparing age 30 to age 50. †Relative risk
e risk comparing 5 years’ difference. §Relative risk comparing meanterizatio
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Post-Transplant Diastolic Dysfunction September 11, 2007:1064–9enous pressure might help identify a subgroup of patients
ith a worse prognosis. In addition, when the elevated
ight-sided filling pressures are associated with a depressed
ardiac output, manifested by higher RA/SV ratio, then the
ssociation with cardiac mortality is even stronger. This
ltered ratio probably identifies a group of patients with
igher diastolic impairment, because the higher filling
ressures are no longer enough to maintain an adequate
ardiac output, possibly an indirect measurement of RV
tiffness. Other studies suggest that early post-transplant
D is generally benign and reversible. In our study, we used
weeks as the “early” time point. By 6 weeks, most of the
arly changes resulting from perioperative insults like isch-
mia have subsided, with normalization of Doppler diastolic
arameters (7), but occasionally major histostructural
hanges can be detected (11). Interestingly, in our study, the
resence of RV DD at 6 weeks defined a subgroup of
atients with a higher incidence of RV DD at 1 year (40%
hen present at 6 weeks, vs. 2% when not), indicating that
he histostructural changes that might occur early on might
lready be a pathological response, resulting in the subse-
uent development of DD. The present study is the first to
ystematically analyze the prognostic implications of RV
D in heart transplant recipients. Despite its hemodynamic
mportance, less attention has been given to the RV systolic
nd diastolic function in various cardiac conditions. In
atients with heart failure due to LV systolic dysfunction,
he presence of RV systolic failure is an important predictor
f morbidity and mortality (12,13). In addition, the pres-
nce of RV DD, manifested by echocardiographic abnor-
alities of the tricuspid inflow pattern, is frequent and
ndependent of increased RV afterload (14). Elevated RAP
Figure 3 RV DD and Cardiac Death
Actuarial survival for differing categories of right ventricular (RV) diastolic dys-
function (DD). The error bars enclose  1 SE. Right ventricular DD is defined
in terms of RAP/SV, and at each time point (6 weeks, 6 months, 1 year) is the
value of RAP/SV at which discrimination in survival is possible at p  0.05.
Abbreviations as in Figures 1 and 2.as also been found to be an independent risk factor forortality in patients with pulmonary arterial hypertension
15). The exact mechanism of the association of RV DD in
eart transplant recipients and mortality is unknown, but we
an postulate that the presence of elevated RAP in post-
ransplant patients is the result of abnormal histostructural
hanges that lead to restrictive physiology of the RV in heart
llografts. It might be that the mere presence of an elevated
AP, with its associated complications of peripheral edema
nd liver congestion, might make patients more susceptible
o additional stresses on cardiac function, such as episodes of
ejection or infection, especially in patients with a depressed
ardiac output already. Of note, our study included data
btained during the first year after transplantation; so it
emains unknown whether this phenomenon is an adverse
early” event that would later disappear or a surrogate for the
ubsequent development of biventricular DD.
In summary, our study suggests that DD is common early
fter transplant and its incidence decreases during the first
ear. Although uncommon, RV DD but not LV DD at 1
ear is a strong and important predictor of mortality,
specially if associated with a depressed cardiac output.
herefore, we postulate that the continued hemodynamic
ssessment of the cardiac allograft should be part of the
outine evaluation of heart transplant recipients, at least
uring the first year. Further studies are needed to evaluate
he impact of these hemodynamic derangements long-term,
ot only with respect to mortality but also in terms of
unctional status and quality of life. More intriguing is
hether aggressive medical therapy for early DD could alter
he likelihood of subsequent DD and its potential long-term
ffects on patients.
Limitations of our study result from its retrospective nature.
t should be viewed as hypothesis-generating and not a
efinitive answer. Because of its retrospective character, further
odalities to measure diastolic function were not included,
uch as Doppler indexes by echocardiography, nuclear ven-
riculography, or cardiac magnetic resonance. Moreover, our
tudy looks at the presence of DD up to 1 year after transplant.
dditional studies are needed to follow these patients over
rolonged periods of time to assess the incidence and prog-
ostic significance several years after transplant.
eprint requests and correspondence: Dr. José A. Tallaj, Uni-
ersity of Alabama at Birmingham, THT 338, 1900 University
oulevard, Birmingham, Alabama 35294. E-mail: jtallaj@uab.edu.
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